| Literature DB >> 34607572 |
Innocentia Nji Ngong1, Jerome Fru-Cho1, Melduine Akom Yung1, Jane-Francis Kihla Tatah Akoachere2.
Abstract
BACKGROUND: Urinary tract infections (UTIs) are the second most frequent infections after respiratory tract infections that affect humans, with over 150 million cases per year. The anatomy of the female urinary tract predisposes them to UTIs than men. More so, physiological and hormonal changes during pregnancy put pregnant woman at risk of UTIs. Untreated UTI(s) in pregnancy can be detrimental to both the mother and child causing preterm labour, low birth weight and pyelonephritis. The situation is worrisome because the infection can be asymptomatic. This study investigated the prevalence and risk factors for UTIs, diagnostic potential of dipstick analyses and antimicrobial susceptibility of uropathogens from pregnant women attending ANC in some Integrated Health Centers (IHCs) in Buea Health District (BHD).Entities:
Keywords: Antibiotic susceptibility; Pregnancy; Risks factors; Urinary tract infection
Mesh:
Year: 2021 PMID: 34607572 PMCID: PMC8489089 DOI: 10.1186/s12884-021-04142-4
Source DB: PubMed Journal: BMC Pregnancy Childbirth ISSN: 1471-2393 Impact factor: 3.007
Characteristics of study participants
| Parameter | n (%) | |
|---|---|---|
| ≤ 20 | 34 (11.9) | |
| 21–25 | 96 (33.5) | |
| 26–30 | 93 (32.4) | |
| 31–40 | 60 (21.0) | |
| >40 | 4 (1.4) | |
| Illiterate | 4 (1.4) | |
| Primary | 29 (10.8) | |
| Secondary | 159 (55.8) | |
| Tertiary | 93 (32.6) | |
| Single | 90 (31.4) | |
| Married | 196 (68.3) | |
| Separated/Divorce | 1 (0.4) | |
| 1st trimester | 17 (6.0) | |
| 2nd trimester | 109 (38.0) | |
| 3rd trimester | 161 (56.1) | |
| Primigravida | 110 (38.3) | |
| Multigravida | 177 (61.7) | |
| Nullipara | 120 (41.8) | |
| Multipara | 167 (58.8) | |
| Gestational age at first ANC | 1st trimester | 107 (37.3) |
| 2nd trimester | 173 (60.3) | |
| 3rd trimester | 7 (2.4) | |
| ≤19 | 52 (18.1) | |
| 20–29 | 190 (66.2) | |
| 30–39 | 42 (14.6) | |
| >40 | 3 (1.1) | |
| Yes | 231 (80.5) | |
| No | 56 (19.5) | |
Prevalence of asymptomatic bacteriuria
| Culture | Characteristics | |||
|---|---|---|---|---|
| Symptomatic | Asymptomatic | Total | χ2 ( | |
| 46 (33.6) | 43 (28.7) | 89 (31.0) | 0.59 (0.44) | |
| 91 (66.4) | 107 (71.3) | 198 (69.0) | ||
| Total | 137 | 150 | 287 (100) | |
Prevalence of uropathogens in samples
| Type of bacteria | n (%) | |
|---|---|---|
| Gram positive | Coagulase negative Staphylococcu | 5 (5.6) |
| 8 (9.0) | ||
| Gram | 38 (43.2) | |
| Negatives | 3 (3.4) | |
| 17 (19.1) | ||
| 5 (5.6) | ||
| 7 (7.9) | ||
| 5 (5.6) | ||
| 1 (1.1) | ||
| Total | 76 (85.4) | |
| Grand Total | 89 (31.0) | |
Demographic, obstetric and behavioral characteristics as risk factors for UTI
| Culture Status | χ2 ( | ||||
|---|---|---|---|---|---|
| Risk factors | Parameter | Positive | Negative | OR | |
| Primigravida | 34 (38.2) | 76 (38.4) | 1.01 (0.60–1.68) | 0.01 (0.92) | |
| Multigravida | 122 (61.6) | ||||
| Nulliparous | 36 (40.4) | 54 (27.3) | 1.08 (0.65–1.8) | 0.03 (0.85) | |
| Multiparous | 144 (72.7) | ||||
| 1st trimester | 8 (9.0) | 9 (4.5) | 2.96 (0.23) | ||
| 2nd trimester | 36 (40.4) | 73 (36.9) | |||
| 3rd trimester | 45 (50.6) | 116 (58.6) | |||
| ≤Teen age 19 | 163 (82.3) | 0.9 (0.4–1.7) | 0.02 (0.91) | ||
| >Teen age 19 | 17 (19.1) | 35 (17.7) | |||
| 63 (70.8) | 147 (74.2) | 1.2 (0.66–2.08) | 0.37 (0.54) | ||
| >30 | 51 (25.8) | ||||
| Single/divorced | 24 (27.0) | 66 (33.3) | 0.73 (0.42–1.28) | 1.67 (0.43) | |
| Married | 65 (73.0) | 132 (66.7) | |||
| Illiterates and basic | 6 (18.2) | 27 (81.8) | 0.46 (0.18–1.15) | 3.76 (0.21) | |
| Above basic | 83 (32.7) | 171 (67.3) | |||
| 37 | 70 (35.4) | 0.77 (0.46–1.28) | 1.02 (0.31) | ||
| >3 months | 52 (58.4) | 128 (64.4) | |||
| Yes | 69 (77.5) | 162 (81.8) | 0.77 (0.41–1.42) | 0.45 (0.49) | |
| No | 20 (22.5) | 36 (18.2) | |||
| No | 74 (83.1) | 169 (85.8) | 0.84 (0.41–1.92) | 0.79 (0.68) | |
| Yes | 15 (16.9) | 28 (14.2) | |||
| Present | 23 (30.7) | 30 (19.2) | 0.5 (0.62–1.68) | 4.23 (0.12) | |
| Absent | 52 (69.3) | 126 (80.8) | |||
| ≤4 times | 121 (74.2) | 1.7 (0.94–3.10) | 3.07 (0.07) | ||
| >4 times | 26 (37.1) | 42 (25.8) | |||
Hygiene and sanitation of participants as risk factors for UTI
| Parameter | Positive culture | Negative culture | OR | χ | |
|---|---|---|---|---|---|
| Pit | 34 (33.3) | 68 (66.7) | 1.29 (0.55) | ||
| Water cistern | 48 (31.2) | 109 (68.3) | |||
| Bucket | 7 (22.6) | 24 (77.4) | |||
| Shared | 33 (28.2) | 84 (71.8) | 0.8 (0.48–1.33) | 0.73 (0.39) | |
| Personal | 56 (32.9) | 144 (67.1) | |||
| 1–3 | 21 (37.5) | 51 (42.8) | 11.1 (0.68) | ||
| 4–6 | 23 (41.0) | 35 (29.5) | |||
| >6 | 12 (21.1) | 33 (27.6) | |||
| Yes | 38 (29.9) | 89 (70.1) | 1.025 | 0.003 (0.859) | |
| No | 17 (37.8) | 28 (62.2) | |||
| Front to back | 76 (32.6) | 157 (67.4) | 1.53 (0.77–3.02) | 1.50 (0.22) | |
| Back to front | 13 (24.1) | 41 (76.0) | |||
| Nylon | 11 (39.3) | 17 (60.7) | 1.49 (0.67–3.34) | 0.59 (0.44) | |
| Cotton | 78 (30.2) | 180 (69.8) | |||
| ≤2 | 11 (39.3) | 17 (60.7) | 0.796 (0.87–2.42) | 0.362 (0.332) | |
| >2 | 7 8 (15.3) | 180 (15.3) | |||
| Yes | 62 (30.4) | 142 (69.2) | 1.04 (0.57–1.91) | 0.02 (0.88) | |
| No | 20 (29.2) | 48 (70.6) | |||
Assessment of maternal physiologic conditions as risk factors for UTI
| Anaemia status | Glocosuria | |||
|---|---|---|---|---|
| Anaemic | Not anaemic | Present | Absent | |
| 12 (32.4) | 77 (30.8) | 5 (41.7) | 84 (30.6) | |
| 25 (67.6) | 176 (69.2) | 7 (58.3) | 191 (69.4) | |
1.08 (0.51–2.26) | 1.6 (0.51–5.3) | |||
0.04 (0.84) | 0.66 (0.41) | |||
Validity and reliability of nitrite and leucocytes in screening for UTI
| Dipstick test | Individual sens | Individual spec | PPV | Net (combined) sens | Net (combined) spec |
|---|---|---|---|---|---|
| 48.3 | 44.9 | 40.9 | 50.6 | 44.9 | |
| 4.5 |
Sens Sensitivity, spec Specificity, PPV Positive predictive value
Antibiotic Susceptibility patterns of isolates
| S | I | R | S | I | R | S | I | R | S | I | R | S | I | R | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10 (26.3) | 3 (7.9) | 25 (65.8) | 13 (26.3) | 15 (42.1) | 10 (31.6) | 0 (0) | 0 (0) | 38 (100) | 0 (0) | 0 (0) | 38 (100) | 5 (13.2) | 0 (0) | 33 (86.8) | |
3 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 3 (100) | 0 (0) | 0 (0) | 3 (100) | 0 (0) | 0 (0) | 3 (100) | 0 (0) | 0 (0) | 3 (100) | |
0 (0) | 10 (58.8) | 7 (41.2) | 12 (70.6) | 5 (29.4) | 0 (0) | 17 (100) | 0 (0) | 0 (0) | 17 (100) | 0 (0) | 0 (0) | 0 (0) | 17 (100) | 0 (0) | |
2 (28.6) | 0 (0) | 5 (71.4) | 2 (28.6) | 5 (71.4) | 0 (0) | 0 (0) | 0 (0) | 7 (100) | 0 (0) | 5 (71.4) | 2 (28.6) | 3 (42.9) | 1 (14.2) | 3 (42.9) | |
0 (0) | 0 (0) | 5 (100) | 0 (0) | 0 (0) | 5 (100) | 5 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 5 (100) | 0 (0) | 3 (60) | 2 (40) | |
8 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 8 (100) | 0 (0) | 0 (0) | 8 (100) | 0 (0) | 0 (0) | 8 (100) | 2 (20) | 0 (0) | 6 (80) | |
30 (78.9) | 5 (13.2) | 3 (7.9) | 15 (39.5) | 0 (0) | 23 (60.5) | 5 (13.6) | 5 (13.6) | 28 (73.7) | 3 (7.9) | 0 (0) | 35 (92.1) | ||||
0 (0) | 3 (100) | 0 (0) | 3 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 3 (100) | 3 (100) | 0 (0) | 0 (0) | ||||
17 (100) | 0 (0) | 0 (0) | 17 (100) | 0 (0) | 0 (0) | 0 (0) | 7 (41.2) | 10 (58.8) | 0 (0) | 0 (0) | 17 (100) | ||||
5 (71.4) | 2 (28.6) | 0 (0) | 7 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 7 (100) | 2 (28.6) | 5 (21.4) | 0 (0) | ||||
2 (100) | 0 (0) | 0 (0) | 5 (100) | 0 (0) | 0 (0) | 5 (100) | 0 (0) | 0 (0) | 0 (0) | 5 (100) | 0 (0) | ||||
2 (22) | 3 (37.5) | 3 (37.5) | 8 (100) | 0 (0) | 0 (0) | 5 (62.5) | 0 (0) | 3 (37.5) | 3 (37.5) | 0 (0) | 5 (62.5) | ||||
CN Gentamycin (20ug), CIP Ciprofloxacin (5ug), SXT Trimethoprim (1.25ug) and sulphamethoxazole (23.75ug), Kanamycin (30ug), C chloramphenicol (5ug), TE Tetracycline (30ug), CRO Ceftriaxone (30ug), CTX Cefatoxime (30ug) and AM Ampicillin (10 mg). S Sensitive, I Intermediate, R Resistant